Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Arbutus Biopharma Corporation Stock Price (Quote) NASDAQ:ABUS
$3.31 ( 2.80% ) Friday, 14th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $3.13 | $4.50 | Friday, 14th Jan 2022 ABUS stock ended at $3.31. This is 2.8% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 6.08% from a day low at $3.13 to a day high of $3.32. |
| 90 days | $3.01 | $6.50 | |
| 52 weeks | $2.43 | $6.50 |
Historical Arbutus Biopharma Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-14 | $3.16 | $3.32 | $3.13 | $3.31 | 2 453 213 |
| 2022-01-13 | $3.33 | $3.34 | $3.22 | $3.22 | 2 437 188 |
| 2022-01-12 | $3.36 | $3.39 | $3.27 | $3.30 | 2 107 590 |
| 2022-01-11 | $3.50 | $3.52 | $3.35 | $3.36 | 2 872 569 |
| 2022-01-10 | $3.53 | $3.59 | $3.38 | $3.52 | 2 234 034 |
| 2022-01-07 | $3.56 | $3.62 | $3.46 | $3.50 | 1 761 997 |
| 2022-01-06 | $3.50 | $3.61 | $3.40 | $3.56 | 2 888 700 |
| 2022-01-05 | $3.76 | $3.77 | $3.52 | $3.53 | 2 646 451 |
| 2022-01-04 | $3.94 | $3.95 | $3.65 | $3.73 | 4 014 885 |
| 2022-01-03 | $3.89 | $4.01 | $3.78 | $3.98 | 2 222 910 |
| 2021-12-31 | $3.86 | $4.03 | $3.84 | $3.89 | 2 914 648 |
| 2021-12-30 | $3.77 | $3.91 | $3.74 | $3.88 | 2 720 182 |
| 2021-12-29 | $3.79 | $3.86 | $3.70 | $3.76 | 3 167 264 |
| 2021-12-28 | $3.85 | $4.01 | $3.78 | $3.82 | 3 677 606 |
| 2021-12-27 | $4.16 | $4.16 | $3.85 | $3.86 | 4 450 429 |
| 2021-12-23 | $4.13 | $4.24 | $4.00 | $4.16 | 4 364 162 |
| 2021-12-22 | $4.33 | $4.33 | $4.13 | $4.16 | 3 088 077 |
| 2021-12-21 | $4.38 | $4.46 | $4.27 | $4.29 | 3 606 423 |
| 2021-12-20 | $4.17 | $4.50 | $4.14 | $4.38 | 7 434 006 |
| 2021-12-17 | $3.85 | $4.34 | $3.78 | $4.28 | 7 839 711 |
| 2021-12-16 | $4.07 | $4.15 | $3.88 | $3.89 | 4 531 898 |
| 2021-12-15 | $4.12 | $4.12 | $3.80 | $4.09 | 5 178 243 |
| 2021-12-14 | $4.25 | $4.58 | $4.02 | $4.14 | 8 353 291 |
| 2021-12-13 | $4.38 | $4.50 | $4.14 | $4.36 | 7 765 667 |
| 2021-12-10 | $4.50 | $4.67 | $4.11 | $4.14 | 7 097 437 |
| 2021-12-09 | $4.11 | $4.60 | $4.08 | $4.31 | 12 376 112 |
| 2021-12-08 | $3.90 | $4.26 | $3.83 | $4.14 | 7 967 966 |
| 2021-12-07 | $3.98 | $4.10 | $3.79 | $3.96 | 19 867 597 |
| 2021-12-06 | $3.99 | $4.01 | $3.54 | $3.71 | 10 061 352 |
| 2021-12-03 | $4.05 | $4.45 | $3.92 | $4.15 | 18 236 827 |
| 2021-12-02 | $4.97 | $5.23 | $4.11 | $4.31 | 72 563 715 |
| 2021-12-01 | $5.15 | $6.50 | $4.13 | $4.61 | 322 127 014 |
| 2021-11-30 | $3.10 | $3.23 | $3.01 | $3.20 | 1 475 983 |
| 2021-11-29 | $3.20 | $3.20 | $3.08 | $3.14 | 1 232 659 |
| 2021-11-26 | $3.18 | $3.21 | $3.07 | $3.13 | 651 802 |
| 2021-11-24 | $3.11 | $3.21 | $3.05 | $3.19 | 720 172 |
| 2021-11-23 | $3.10 | $3.14 | $3.02 | $3.12 | 1 288 763 |
| 2021-11-22 | $3.27 | $3.31 | $3.09 | $3.11 | 1 518 804 |
| 2021-11-19 | $3.28 | $3.37 | $3.27 | $3.30 | 924 125 |
| 2021-11-18 | $3.40 | $3.51 | $3.27 | $3.30 | 1 647 660 |
| 2021-11-17 | $3.30 | $3.37 | $3.24 | $3.29 | 1 093 547 |
| 2021-11-16 | $3.32 | $3.40 | $3.25 | $3.34 | 1 231 132 |
| 2021-11-15 | $3.47 | $3.47 | $3.33 | $3.36 | 1 304 908 |
| 2021-11-12 | $3.50 | $3.50 | $3.34 | $3.47 | 1 456 787 |
| 2021-11-11 | $3.50 | $3.55 | $3.45 | $3.47 | 827 703 |
| 2021-11-10 | $3.47 | $3.67 | $3.46 | $3.48 | 1 229 797 |
| 2021-11-09 | $3.58 | $3.65 | $3.45 | $3.50 | 1 408 381 |
| 2021-11-08 | $3.50 | $3.65 | $3.46 | $3.60 | 2 160 852 |
| 2021-11-05 | $3.59 | $3.70 | $3.40 | $3.48 | 3 637 730 |
| 2021-11-04 | $3.90 | $4.16 | $3.84 | $3.88 | 1 816 651 |
Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically i... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
